Literature DB >> 18415638

[Continuous subcutaneous application of analgesics in a patient suffering from a head and neck tumor.].

I Gralow1, W von Hornstein.   

Abstract

In the pain treatment of patients with incurable head and neck tumors it may be difficult to provide adequate oral drug therapy in the advanced stages. In these cases continuous subcutaneous application of morphine by means of external infusors is an alternative. An example of the method of continuous subcutaneous application of analgesics in pain therapy is shown in a patient suffering from a chondrosarcoma of the maxilla. Because oral pharmacotherapy provided insufficient analgesia in the final stage of the tumor disease, it was replaced by continuous subcutaneous application of morphine hydrochloride. A flexible cannula was inserted into the upper arm and connected to an external portable infusor device. Because of growing tumor infiltration, we progressively increased the morphine dosage. Nevertheless, continous subcutaneous application of droperidol, dexamethasone and clonidine was also needed to achieve much better analgesia. The technical simplicity of this safe and effective treatment make it suitable for outpatient care in tumor clinics.

Entities:  

Year:  1992        PMID: 18415638     DOI: 10.1007/BF02527816

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  9 in total

1.  [Pain treatment in advanced head and neck tumors. Pilot study with continuous subcutaneous administration of morphine].

Authors:  I Gralow; W von Hornstein; J Hidding
Journal:  Dtsch Z Mund Kiefer Gesichtschir       Date:  1991 Mar-Apr

2.  Treatment of severe cancer pain by low-dose continuous subcutaneous morphine.

Authors:  Heinz Drexel; Alexander Dzien; Robert W Spiegel; Alois H Lang; Christoph Breier; Klaus Abbrederis; Josef R Patsch; Herbert Braunsteiner
Journal:  Pain       Date:  1989-02       Impact factor: 6.961

3.  Selection of implantable narcotic delivery systems.

Authors:  S D Waldman; D W Coombs
Journal:  Anesth Analg       Date:  1989-03       Impact factor: 5.108

4.  [Clonidine supplemented analgesia and sedation in prevention of postoperative delirium].

Authors:  L Verner; M Hartmann; W Seitz
Journal:  Anasth Intensivther Notfallmed       Date:  1990-08

5.  Clonidine-induced analgesia in postoperative patients: epidural versus intramuscular administration.

Authors:  F Bonnet; O Boico; S Rostaing; J F Loriferne; M Saada
Journal:  Anesthesiology       Date:  1990-03       Impact factor: 7.892

6.  Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen.

Authors:  T L Yaksh; S V Reddy
Journal:  Anesthesiology       Date:  1981-06       Impact factor: 7.892

Review 7.  Antitumor and antinociceptive approaches to control cancer pain.

Authors:  N Sundaresan; G V DiGiacinto
Journal:  Med Clin North Am       Date:  1987-03       Impact factor: 5.456

8.  Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain.

Authors:  E Bruera; C Brenneis; M Michaud; K MacMillan; J Hanson; R N MacDonald
Journal:  J Natl Cancer Inst       Date:  1988-09-21       Impact factor: 13.506

9.  Subcutaneous infusions for control of cancer symptoms.

Authors:  P Storey; H H Hill; R H St Louis; E E Tarver
Journal:  J Pain Symptom Manage       Date:  1990-02       Impact factor: 3.612

  9 in total
  1 in total

1.  [Slow-release morphine liquid suspension for the therapy of cancer pain and non-cancer pain-A pilot study.].

Authors:  M Strumpf; B Donner; M Zenz
Journal:  Schmerz       Date:  1995-05       Impact factor: 1.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.